Despite expected EPS growth, Harmony Biosciences' low P/E ra...
Despite expected EPS growth, Harmony Biosciences' low P/E ratio signals bearishness as skeptics question its ability to improve declining earnings, potentially capping its stock price. The P/E and growth outlook mismatch suggests investor concerns about unexpected earnings threats.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000323403a4044e23.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment